Reckitt Benckiser Group (OTCMKTS:RBGLY) Shares Gap Up - What's Next?

Key Points

• Reckitt Benckiser Group's stock price gapped up from $14.87 to $15.35 before the market opened, indicating a positive market reaction.
• Analysts are optimistic about the stock, with a consensus rating of "Buy" and recent upgrades from multiple firms, including Royal Bank Of Canada and Sanford C. Bernstein.
• The company has recently cut its dividend despite a substantial yield of 341.0%, which shows a significant increase in share value.

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $14.87, but opened at $15.35. Reckitt Benckiser Group shares last traded at $15.39, with a volume of 40,022 shares.

Analyst Ratings Changes

A number of equities research analysts have commented on RBGLY shares. Royal Bank Of Canada restated an "outperform" rating on shares of Reckitt Benckiser Group in a research note on Friday, July 25th. Sanford C. Bernstein upgraded shares of Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research report on Thursday, June 5th. Three equities research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy".

Reckitt Benckiser Group Stock Up 3.9%

The business's fifty day moving average is $15.10 and its two-hundred day moving average is $13.97. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.56 and a quick ratio of 0.37.

Reckitt Benckiser Group Cuts Dividend

The company also recently disclosed a dividend, which was paid on Thursday, September 25th. Shareholders of record on Monday, August 11th were paid a dividend of $0.2106 per share. This represents a yield of 341.0%. The ex-dividend date of this dividend was Friday, August 8th.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.